Search research articles
Contact Us
Filters
Showing results (31-40 of 37) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 37 results.
Haematologica
|
January 8, 2026
Clinical outcomes of venetoclax combined with hypomethylating agents versus hypomethylating agents alone in <i>TP53</i>-mutated myelodysplastic syndromes
Mahmood Aldapt, Yu-Hung Wang, Kashish J Shah, et al.
Hematological Oncology
|
January 24, 2025
Comprehensive Characterization of Overt Myelofibrosis in an Asian Cohort: Phenotype, Mutation Landscape and Discordance Among Scoring Systems
Yu-Sung Chang, Yu-Hung Wang, Chao-Hung Wei, et al.
British Journal of Haematology
|
November 18, 2025
Genomic and transcriptomic characterization of acute myeloid leukaemia with IL3RA overexpression: Prognostic and therapeutic implications revisited
Chi-Yuan Yao, Chia-Lang Hsu, Yi-Tsung Yang, et al.
Leukemia
|
October 4, 2024
Synergistic effect of concurrent high molecular risk mutations and lower JAK2 mutant variant allele frequencies on prognosis in patients with myelofibrosis-insights from a multicenter study
Yu-Hung Wang, Chao-Hung Wei, Chien-Chin Lin, et al.
British Journal of Haematology
|
February 27, 2024
Validation of the Artificial Intelligence Prognostic Scoring System for Myelodysplastic Syndromes in chronic myelomonocytic leukaemia: A novel approach for improved risk stratification
Adrian Mosquera Orgueira, Manuel Mateo Perez Encinas, Nicolas Diaz Varela, et al.
Blood
|
July 29, 2024
Influence of TP53 gene mutations and their allelic status in myelodysplastic syndromes with isolated 5q deletion
Maria Julia Montoro, Laura Palomo, Claudia Haferlach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 27, 2026
Molecular-Based Ecosystem to Improve Personalized Medicine in Chronic Myelomonocytic Leukemia
Luca Lanino, Anthony M Hunter, Nico Gagelmann, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 37) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 37 results.
Haematologica
|
January 8, 2026
Clinical outcomes of venetoclax combined with hypomethylating agents versus hypomethylating agents alone in <i>TP53</i>-mutated myelodysplastic syndromes
Mahmood Aldapt, Yu-Hung Wang, Kashish J Shah, et al.
Hematological Oncology
|
January 24, 2025
Comprehensive Characterization of Overt Myelofibrosis in an Asian Cohort: Phenotype, Mutation Landscape and Discordance Among Scoring Systems
Yu-Sung Chang, Yu-Hung Wang, Chao-Hung Wei, et al.
British Journal of Haematology
|
November 18, 2025
Genomic and transcriptomic characterization of acute myeloid leukaemia with IL3RA overexpression: Prognostic and therapeutic implications revisited
Chi-Yuan Yao, Chia-Lang Hsu, Yi-Tsung Yang, et al.
Leukemia
|
October 4, 2024
Synergistic effect of concurrent high molecular risk mutations and lower JAK2 mutant variant allele frequencies on prognosis in patients with myelofibrosis-insights from a multicenter study
Yu-Hung Wang, Chao-Hung Wei, Chien-Chin Lin, et al.
British Journal of Haematology
|
February 27, 2024
Validation of the Artificial Intelligence Prognostic Scoring System for Myelodysplastic Syndromes in chronic myelomonocytic leukaemia: A novel approach for improved risk stratification
Adrian Mosquera Orgueira, Manuel Mateo Perez Encinas, Nicolas Diaz Varela, et al.
Blood
|
July 29, 2024
Influence of TP53 gene mutations and their allelic status in myelodysplastic syndromes with isolated 5q deletion
Maria Julia Montoro, Laura Palomo, Claudia Haferlach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 27, 2026
Molecular-Based Ecosystem to Improve Personalized Medicine in Chronic Myelomonocytic Leukemia
Luca Lanino, Anthony M Hunter, Nico Gagelmann, et al.
Page
of 4